Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT)

Lancet

Volumn 352, Issue 9145, 1998, Pages 1965-1969

  Sourander, Leif ^a   Rajala, T ^a   Raiha I ^a   Makinen J ^a   Erkkola, R ^a   Helenius, H ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ACUTE HEART INFARCTION; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; ENDOMETRIUM CANCER; ESTROGEN THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; STROKE; SUDDEN DEATH;

EID: 0032570132     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)05066-1     Document Type: Article

References (25)

1. 1 Barrett-Connor, Bush TL. Estrogen and coronary heart disease in women. JAMA 1991; 265: 1861-67.
2. 2 Stampfer MJ, Colditz GA. Estrogen replacement and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991; 20: 47-63.
3. 3 Grodstein F, Stampfer M. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis 1995; 38: 199-210.
4. 4 Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P. Prior to use of estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol 1996; 142: 971-78.
5. 5 Grodstein F. Invited commentary: can selection bias explain the cardiovascular benefits of hormone replacement therapy? Am J Epidemiol 1996; 143: 979-82.
6. 6 Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P. Health prior to hormone use: reply to Grodstein. Am J Epidemiol 1996; 143: 983-84.
7. 7 Lobo RA. The role of progestogens in hormone replacement therapy. Am J Obstet Gynecol 1992; 168: 1997-2004.
8. 8 Sismondi P, Biglia N, Gioi M, Campognoli C. Hormone replacement therapy and breast cancer. Eur Menop J 1996; 3: 227-31.
9. 9 Population census 1970: occupation and social position. Official Statistics of Finland VI C: 104, vol IX. Helsinki: Central Statistical Office of Finland, 1974.
10. 10 Causes of death. Statistics Finland: Helsinki, 1996.
11. 11 Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry: experience in Finland. Acta Oncol 1994; 33: 365-69.
12. 12 Collett D. Modeling survival data in medical research. London: Chapman and Hall, 1994.
13. 13 Grodstein F, Stampfer MJ, Manson JE, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996; 335: 453-61.
14. 14 Henderson BE, Paganini-Hill A, Ross RK. Mortality in users of estrogen replacement therapy. Ann Intern Med 1991; 151: 75-78.
15. 15 Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease: ten years follow-up from the Nurses' Health Study. N' Engl J Med 1991; 325: 756-62.
16. 16 Wilson PWF, Garrison RJ, Castelli WP. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50: the Farmingham Study. N Engl J Med 1985; 313: 1038-43.
17. 17 Davies MJ, Thomas A. Thrombosis and acute coronary lesions in sudden cardiac ischemic death. N Engl J Med 1984; 310: 1137-40.
18. 18 Huikuri HV, Pikkujämsä SM, Airaksinen KEJ, et al. Sex-related differences in autonomic modulation of heart rate in middle-aged subjects. Circulation 1996; 94: 122-25.
19. 19 Akhtar M, Myerburg RJ, Ruskin IN, eds. Sudden cardiac death: prevalence, mechanisms and approaches to diagnosis and management. Baltimore: Williams and Wilkins, 1994.
20. 20 Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestogens and the risk of breast cancer in postmenopausal women. N Engl J Med 1995; 332: 1589-93.
21. 21 Stanford J, Weiss N, Voigt L, et al. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle aged women. JAMA 1995; 274: 137-42.
22. 22 Newcomb PA, Longnecker MP, Storer BE, et al. Long-term hormone replacement therapy and risks of breast cancer in postmenopausal women. Am J Epidemiol 1995; 142: 788-95.
23. 23 Pukkala E. Cancer risk by social class and occupation: a survey of 109 000 cancer cases among Finns of working age. In: Wahrendorf J, ed. Contribution to epidemiology and biostatistics, vol 7. Basel: Karger, 1995.
24. 24 Katsouyanni K, Trichopoulou A, Struver S, et al. Ethanol and breast cancer: an association that may both be confounded and casual. J Clin Endocrinol Metab 1997; 82: 1549-56.
25. 25 Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and oestrogen replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer. Lancet 1997; 350: 1047-59.